YourChoice Therapeutics logo
Healthcare & Life Sciences

YourChoice Therapeutics

YourChoice Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
1
Investors

About YourChoice Therapeutics

YourChoice Therapeutics is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

YourChoice Therapeutics is developing YCT-529, a selective retinoic acid receptor-alpha antagonist as an oral, non-hormonal male contraceptive currently in Phase 2 clinical trials.

Explore YourChoice Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States